Clinical efficacy of Xuezhikang maintenance treatment for senile hyperlipidemia
10.3760/cma.j.issn.1008-6706.2014.s2.003
- VernacularTitle:血脂康维持治疗老年人高脂血症的临床疗效观察
- Author:
Yang WANG
- Publication Type:Journal Article
- Keywords:
Hyperlipidemias;
Xuezhikang;
Rosuvastatin;
Aged
- From:
Chinese Journal of Primary Medicine and Pharmacy
2014;(z2):7-8,9
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical curative effect of Xuezhikang maintaining treatment for senile hyperlipidemia.Methods According to the digital table,96 elderly patients with hyperlipidemia were selected and randomly divided into the three groups.The control group 1 with 32 cases took orally rosuvastatin before sleeping 10mg per time,1 time /day,12 weeks one treatment course.The control group 2 with 32 cases took orally Xuezhikang capsule before sleeping 0.6g 2 times/day,12 weeks one treatment course.The treatment group with 32 cases took first orally rosuvastatin before sleeping 10 mg/time,1 time /day for 4 weeks,then changed to use Xuezhikang capsule 0.6g 2 times/day for six weeks.The total treatment course was 12 weeks.Results After treatment,TC,TG,LDL-C in three groups all declined significantly and HDL-C increased.The curative effect was similar in treatment group and control group 1 with no statistical difference(P >0.05).Conclusion Xuezhikang has similar efficacy with rosuvastatin 10 mg/time in hyperlipidemia,and recommand Xuezhikang clinical use for its lower price.
